ABCG1 and endothelial function
ABCG1 和内皮功能
基本信息
- 批准号:8207861
- 负责人:
- 金额:$ 40.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-03 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:7-ketocholesterolATP-Binding Cassette TransportersAnimal ModelAntiatherogenicApolipoprotein A-IApolipoprotein EApolipoproteinsArterial Fatty StreakAtherosclerosisBiological AvailabilityBreedingCalmodulinCaveolaeCaveolinsCell Adhesion MoleculesCell modelCellsCharacteristicsCholesterolComplexDataDefectDietEndothelial CellsEndotheliumFunctional disorderGene Transfer TechniquesGenerationsGenetic RecombinationHigh Density LipoproteinsHumanInflammatoryInfusion proceduresKnock-outLinkMediatingMusNADPH OxidasePlasmaPlayRelaxationResistanceRoleSignal TransductionSmall Interfering RNASterolsTestingTransgenesatherogenesiscadherin 5caveolin 1chemokinecytokinefeedinghuman NOS3 proteinimprovedin vivoinsightknock-downnoveloverexpressionparticleprotective effectreconstitutionresearch studyunpublished works
项目摘要
Plasma high density lipoproteins (HDL) have a protective effect in atherosclerosis but
the underlying mechanisms are incompletely understood. A part of the athero-protective
effect of HDL may be related to its ability to reverse endothelial dysfunction, a
characteristic feature of early atherosclerotic lesions involving decreased bioavailability
of eNOS-derived NO and increased expression of cell adhesion molecules and
inflammatory chemokines and cytokines. Many of the beneficial effects of HDL appear to
be related to its ability to promote efflux of cholesterol and toxic oxysterols from cells via
the ATP binding cassette transporters, ABCA1 and ABCG1. ABCG1 is highly expressed
in endothelial cells and has an essential role in promoting efflux of cholesterol and 7-
oxysterols to HDL. Our recent studies show that high cholesterol diet-fed Abcg1-/-
develop a severe defect in eNOS-dependent relaxation of arterial segments, associated
with accumulation of 7-ketocholesterol and disruption of the active, dimeric form of
eNOS. In cholesterol-loaded human aortic endothelial cells (HAECs), knock-down of
ABCG1 results in decreased eNOS activity and. This leads to the central hypothesis that
ABCG1 has an anti-atherogenic role in endothelium. In Aim 1 we propose to investigate
cellular mechanisms responsible for decreased eNOS activity and increased expression
of cell adhesion molecules in ABCG1-deficient cells. The central concept we will test is
whether there is increased formation of inhibitory eNOS/Caveolin complexes, increased
caveolar localization and activation of signaling complexes involving NADPH oxidases.
In Aims 2 and 3 we will use recently developed Abcg1flox/flox mice to carry out endothelial-
specific knock-out of ABCG1. These mice will be crossed with Ldlr-/- mice to determine
whether there is reduced eNOS activity, increased expression of cell adhesion
molecules and increased atherogenesis. We will also determine if these mice are
resistant to the athero-protective effects of increased HDL levels induced by infusions of
reconstituted HDL or apoA-1 transgenesis. These studies will use novel animal and
cellular models to provide new insights into the mechanisms of athero-protective effects
of HDL involving arterial endothelium.
血浆高密度脂蛋白(HDL)在动脉粥样硬化中具有保护作用,
其潜在机制尚未完全了解。动脉粥样硬化保护的一部分
HDL的作用可能与其逆转内皮功能障碍的能力有关,
早期动脉粥样硬化病变的特征性特征,包括生物利用度降低
eNOS衍生的NO和细胞粘附分子的表达增加,
炎性趋化因子和细胞因子。HDL的许多有益作用似乎
与其促进胆固醇和毒性氧化固醇从细胞中流出的能力有关,
ATP结合盒转运蛋白ABCA 1和ABCG 1。ABCG 1高表达
在内皮细胞中,并在促进胆固醇和7-
氧化固醇与HDL的比值。我们最近的研究表明,高胆固醇饮食喂养的Abcg 1-/-
在eNOS依赖的动脉段舒张中出现严重缺陷,
随着7-酮胆固醇的积累和活性二聚体形式的破坏,
eNOS。在胆固醇负载的人主动脉内皮细胞(HAECs)中,
ABCG 1导致eNOS活性降低,这就引出了一个中心假设,
ABCG 1在内皮中具有抗动脉粥样硬化作用。在目标1中,我们建议调查
eNOS活性降低和表达增加的细胞机制
ABCG 1缺陷细胞中的细胞粘附分子。我们将测试的中心概念是
是否存在抑制性eNOS/小窝蛋白复合物的形成增加,是否存在抑制性eNOS/小窝蛋白
小窝定位和激活涉及NADPH氧化酶的信号复合物。
在目的2和3中,我们将使用最近开发的Abcg 1flox/flox小鼠进行内皮细胞-
ABCG 1的特异性敲除。将这些小鼠与Ldlr-/-小鼠杂交以确定
是否存在eNOS活性降低、细胞粘附表达增加
分子和增加动脉粥样硬化。我们还将确定这些小鼠是否
抵抗由输注以下物质诱导的HDL水平升高的动脉粥样硬化保护作用
重组HDL或apoA-1转基因。这些研究将使用新的动物和
细胞模型,为动脉粥样硬化保护作用的机制提供新的见解
高密度脂蛋白影响动脉内皮细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN richard TALL其他文献
ALAN richard TALL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN richard TALL', 18)}}的其他基金
New therapeutic approaches in clonal hematopoiesis and atherosclerosis
克隆造血和动脉粥样硬化的新治疗方法
- 批准号:
10719058 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Clonal hematopoiesis, inflammasomes and atherosclerosis
克隆造血、炎症小体和动脉粥样硬化
- 批准号:
10581564 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
Clonal hematopoiesis, inflammasomes and atherosclerosis
克隆造血、炎症小体和动脉粥样硬化
- 批准号:
10339390 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
Hyperinsulinemia, mTOR activity and plasma lipoproteins
高胰岛素血症、mTOR 活性和血浆脂蛋白
- 批准号:
8275590 - 财政年份:2012
- 资助金额:
$ 40.25万 - 项目类别:
ABCA1/G1 and LXRs in Atherogenesis
ABCA1/G1 和 LXR 在动脉粥样硬化形成中的作用
- 批准号:
10171606 - 财政年份:2011
- 资助金额:
$ 40.25万 - 项目类别:
ABCA1/ABCG1 in myeloid populations and atherogenesis
ABCA1/ABCG1 在骨髓细胞群和动脉粥样硬化形成中的作用
- 批准号:
8675919 - 财政年份:2011
- 资助金额:
$ 40.25万 - 项目类别:
相似海外基金
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10390366 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10237095 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10552563 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
Photosensitizing Nanoconstructs for Regulation of ATP-Binding Cassette Transporters in the Brain
用于调节大脑中 ATP 结合盒转运蛋白的光敏纳米结构
- 批准号:
2030253 - 财政年份:2020
- 资助金额:
$ 40.25万 - 项目类别:
Standard Grant
Structural and functional studies of iron uptake ATP-binding cassette transporters (ABC transporters) in Gram-negative bacteria
革兰氏阴性菌中铁摄取 ATP 结合盒转运蛋白(ABC 转运蛋白)的结构和功能研究
- 批准号:
20K22561 - 财政年份:2020
- 资助金额:
$ 40.25万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2018
- 资助金额:
$ 40.25万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2017
- 资助金额:
$ 40.25万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2016
- 资助金额:
$ 40.25万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
The Mechanism of ATP Binding Cassette Transporters
ATP 结合盒转运蛋白的机制
- 批准号:
318360 - 财政年份:2014
- 资助金额:
$ 40.25万 - 项目类别:
Fellowship Programs
Heat shock protein 27 attenuates foam cell formation by enhancing cholesterol efflux via the ATP-binding cassette transporters A1
热休克蛋白 27 通过 ATP 结合盒转运蛋白 A1 增强胆固醇流出,从而减弱泡沫细胞形成
- 批准号:
304334 - 财政年份:2014
- 资助金额:
$ 40.25万 - 项目类别: